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ABSTRACT
The murine developing epicardium heterogeneously expresses the
transcription factors TCF21 and WT1. Here, we show that this cell
heterogeneity is conserved in human epicardium, regulated by BNC1
and associated with cell fate and function. Single cell RNA sequencing
of epicardium derived from human pluripotent stem cells (hPSC-epi)
revealed that distinct epicardial subpopulations are defined by high
levels of expression for the transcription factors BNC1 or TCF21.WT1+
cells are included in the BNC1+ population, which was confirmed in
human foetal hearts. THY1 emerged as a membrane marker of the
TCF21 population. We show that THY1+ cells can differentiate into
cardiac fibroblasts (CFs) and smooth muscle cells (SMCs), whereas
THY1− cells were predominantly restricted to SMCs. Knocking down
BNC1during the establishment of the epicardial populations resulted in
a homogeneous, predominantly TCF21high population. Network
inference methods using transcriptomic data from the different cell
lineages derived from the hPSC-epi delivered a core transcriptional
network organised aroundWT1, TCF21 and BNC1. This study unveils
a list of epicardial regulators and is a step towards engineering
subpopulations of epicardial cells with selective biological activities.
KEY WORDS: Epicardium, Human pluripotent stem cells, Heart
development, Regenerative medicine, BNC1, Single cell
INTRODUCTION
The epicardium is an epithelium covering the heart, which is
essential for normal cardiac development. Epicardial cells originate
from the pro-epicardial (PE) organ, an outgrowth of non-cardiac,
coelomic and proliferative cells located between the heart and the
liver (Smits et al., 2018). During embryonic life, the epicardium
provides signals for proliferation, survival and maturation to the
cardiomyocytes. In return, the myocardium provides signals
inducing proliferation and epithelial-to-mesenchymal transition
(EMT) in the epicardium. The mesenchymal cells derived from
the epicardium (EPDCs) invade the myocardium and become
mainly cardiac fibroblasts (CFs) and coronary smooth muscle cells
(cSMCs). Surgical ablation of the PE organ leads to cardiac
developmental abnormalities (Gittenberger-De Groot et al., 2000).
In the adult, the epicardium is quiescent. It becomes reactivated
after ischemic injury but produces EPDCs that are less efficient at
migrating and differentiating than their embryonic counterparts.
They produce signals that activate the resident CFs, inducing
fibrosis but no myogenesis. Some animals, such as the zebrafish and
the neonatal (but not adult) mouse, can fully regenerate the heart
(Poss et al., 2002; Chablais et al., 2011; Porrello et al., 2011). The
adult epicardium is necessary for this regeneration potential
(Schnabel et al., 2011). For example, after injury in zebrafish,
PDGF signalling is activated in the newly produced EPDCs
allowing them to proliferate and contribute to new coronary vessels
(Kim et al., 2010). The regenerating epicardium also secretes the
cytokine Cxcl12a, which directs the migration of proliferating
cardiomyocytes towards the wound. This migration is altered by
blocking Cxcr4b, the receptor for Cxcl12a (Itou et al., 2012). A
better knowledge of human epicardium could explain and allow us
to circumvent the regenerative limitations of the adult heart (Masters
and Riley, 2014; Risebro et al., 2015; Smits et al., 2018).
A number of genes expressed in the epicardium that have key
regulatory roles have been described. The most important groups for
development and function are signalling molecules and growth
factors belonging to the FGF, TGF, PDGF,WNT and other families,
cell-to-cell adhesion molecules such as E-cadherin or zonula
occludens-1 and transcription factors (Braitsch and Yutzey, 2013).
The best characterised markers in the epicardial literature are two
transcription factors: Wilms’ tumor 1 (WT1) and transcription factor
21 (TCF21). TCF21 is a basic helix-loop-helix transcription factor
essential for the determination of the CF lineage (Acharya et al.,
2012). WT1 is a zinc-finger transcription factor essential for EMT
(Martínez-Estrada et al., 2010; von Gise et al., 2011). Interestingly,
they are both already expressed in the PE cells, downregulated in the
adult epicardium, and reactivated after myocardial ischemic injury.
Previous studies suggested that the epicardium comprises
different cell types, with distinct functions (Simões and Riley,
2018; Smits et al., 2018; Weinberger et al., 2018). However, little is
known about the molecular regulation of this cellular heterogeneity,
except that WT1 and TCF21 are heterogeneously expressed within
the mouse epicardium (Braitsch et al., 2012). Identifying the
molecular signatures of the various epicardial cells may unveil their
different functions. Because a better understanding of the
epicardium could pave the way to treating the adult heart
following injury, we and others have recently developed and
validated protocols to generate in vitromodels of human developing
epicardium from human pluripotent stem cells (hPSC-epi) (WittyReceived 30 November 2018; Accepted 21 November 2019
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et al., 2014; Iyer et al., 2015; Bao et al., 2017; Guadix et al., 2017;
Zhao et al., 2017). We hypothesised that analysing gene expression
at the single cell level in our systemwill provide key insights into the
molecular and functional regulation of the different human
epicardial cell populations.
RESULTS
Molecular cell heterogeneity in hPSC-epi and human foetal
epicardial explant culture
First, we determined the extent of epicardial marker heterogeneity in
hPSC-epi cultures. Because both antibodies suitable for the
detection of TCF21 and WT1 in human cells were rabbit in
origin, we were previously limited to a flow cytometry strategy in
which the presence of double-positive cells in the hPSC-epi was
indirectly estimated (Iyer et al., 2015). In the present study, we
differentiated the hPSC-epi according to the protocol previously
published (Fig. 1A). Then, we co-immunostained using an anti-
TCF21 antibody plus an Alexa 568-conjugated secondary with
sequential application of an anti-WT1 antibody directly conjugated
to Alexa 488. This confirmed a clear heterogeneity in the hPSC-epi
(Fig. 1B) with single- and double-positive cells. To validate the
in vitro hPSC-derivedmodel, we generated explant cultures of primary
epicardium from 8 week human foetal hearts; co-immunostaining
revealed similar heterogeneity in the foetal explants to that
observed in the hPSC-derived cells (Fig. 1C). We then sequenced
the transcriptome of the hPSC-epi at single cell resolution in order
to characterise precisely the molecular heterogeneity of these cells and
to determine its physiological regulation and functional relevance.
scRNA-seq revealed WT1, TCF21 and BNC1 as indicators of
hPSC-epi functional heterogeneity
Using a Smart-Seq2-based protocol previously used to analyse
mouse embryonic cells (Scialdone et al., 2016), we obtained high-
quality transcriptomes for a total of 232 hPSC-epi single cells. We
examined the variation of TCF21 and WT1 expression in the
population using single cell RNA sequencing (scRNA-seq). As we
were using a monolayer of cells obtained from a simple in vitro
differentiation protocol, we expected subtle levels of heterogeneity
in the sequencing data. Indeed, in a principal component analysis
(PCA), the first two components only absorbed 2.5% and 2.4% of
the variance, respectively. Moreover, the subsequent Eigen values
were much smaller, and 195 components were needed to absorb
90% of the variance. The strongest loadings of TCF21 and WT1
were on the second component (PC2). Over-representation analyses
using the 100 genes with strongest negative and positive PC2
loadings defined two different molecular signatures on the TCF21
andWT1 sides. Among the top genes on the TCF21 side (Fig. 2A),
the strongest is coding for fibronectin (FN1), with others coding for
thrombospondin (THBS1), THY1, CDH7, BAMBI and adenosine
receptor 2B (ADORA2B) (Fig. S1). On theWT1 side, the strongest
is coding for the podocalyxin (PODXL), with others coding for
basonuclin (BNC1, second strongest positive loading on PC2),
P-cadherin (cadherin 3; CDH3) and E-cadherin (cadherin 1; CDH1).
The distribution of expression for TCF21, WT1 and BNC1 was
bimodal, with a large population of cells showing no expression at
all (106, 154 and 45 cells, respectively) (Fig. 2B). It is likely that
some of those ‘zeroes’ are dropouts (Andrews and Hemberg, 2019).
However, the locations of those cells on the PCA plot suggest that
they are not randomly distributed and most of them, at least when it
comes to TCF21 and BNC1 expression, reflect true subpopulations.
Twenty-seven cells (12%) expressed all three markers. Colouring
the PCA plot with TCF21,WT1 and BNC1 expression clearly shows
two populations segregated along PC2 (Fig. 2C). With a few
exceptions, WT1-expressing cells form a subpopulation of BNC1-
expressing cells. Cells strongly expressing BNC1 are mostly devoid
of TCF21 expression (see also Fig. S2A). Finally, immunofluorescence
detection of BNC1 and WT1 confirmed the correlation between the
high level of WT1 and high level of BNC1 and the inclusion of WT1+
cells in the BNC1+ population in the hPSC-epi (Fig. 2D).
Immunostaining of foetal human heart sections at 8 weeks pc
demonstrated the expression of BNC1 in the epicardium and
confirmed a heterogeneous distribution of the protein (Fig. 2E).
Immuno-staining of human embryonic epicardial explants from
human hearts at 8 weeks post-conception (pc) confirmed co-
location of WT1 and BNC1 (Fig. 2F).
BNC1 and TCF21 are not just markers of two subpopulations;
they also reflect the state of the entire transcriptome. We computed
the Pearson correlation of BNC1, WT1 and TCF21 expression with
all the expressed and variable genes (Fig. S2B). Comparing these
correlations, we observe that if the expression of a gene correlates
with TCF21 expression, it does not correlate with BNC1 expression
(Pearson correlation of −0.454). By contrast, if the expression of a
gene correlates with that of WT1, it also tends to correlate with
BNC1 expression (Pearson correlation of 0.293).
The hPSC-epi is composed of a BNC1 and a TCF21 population
Cell subpopulations of hPSC-epi cannot be solely based on the
expression ofTCF21 andBNC1 because of the presence of dropouts –
genes for which expression is measured as 0 not because there is
no mRNA, but because the mRNA was not reverse-transcribed.
Instead, we generated cell similarities using t-distributed stochastic
neighbour embedding (t-SNE), exploring different parameter
values. The lowest Kullback–Leibler divergence (a measure of
how well the t-SNE distances represents the actual distances in
genome space) corresponded with final distributions in three groups
of cells. We attributed cells to each group using a partition around
medoid approach, resulting in three clusters of different sizes (146,
62 and 24 cells; Fig. 3A). The largest cluster expressed considerably
more BNC1 than TCF21, the intermediate showed the opposite, and
the smallest cluster comprised both types of cells (Fig. 3B). We used
DESeq2 to compare gene expression between each pair of clusters.
Enrichment analysis on the resulting gene sets showed that the small
cluster exhibits a clear signal for mitosis (Table S1). When we
corrected for a cell-cycle component with the single cell latent
variable model (Buettner et al., 2015; Andrews and Hemberg, 2019)
before running t-SNE and clustering, the small cluster disappeared,
suggesting it was not a true subpopulation. To avoid confusion,
these 24 mitotic cells were omitted in further analyses.
Molecular signature of BNC1high and TCF21high populations
Differential gene expression analysis revealed that 2494 genes were
differentially expressed between the largest clusters (Fig. 3A, cyan and
orange): 1454 higher in the BNC1high cells and 1040 higher in the
TCF21high ones (Table S2). In addition to an enrichment of 13.6-fold
inBNC1 expression, theBNC1high cells exhibited 3.6 timesmoreWT1
than did TCF21high cells (Fig. 3C). Genes encoding podocalyxin,
E-cadherin and P-cadherin were also strongly enriched confirming the
positive loading of PCA component 2. In addition to 4.4-fold more
TCF21 expression, the TCF21high cells showed enrichments for
the markers found in the negative loading of PCA component
2. Clustering the cells using 142 strongly expressed (base mean above
100), very significantly (adjusted P-value lower than 10−5) and
strongly enriched (enrichment over 2-fold) genes, reproduced the
clustering based on the whole genome (Fig. 3D). This means that the
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most differentially expressed genes are a good representation of
the whole transcriptional landscape, providing confidence that the
genes significantly differentially expressed between TCF21high and
BNC1high are valid markers to separate the two populations.
The top transcription factors, plasma membrane proteins and
secreted factors upregulated in BNC1high and TCF21high
populations are listed in Table 1. Some of these genes encode for
proteins that had already been flagged in the literature as potential
regulators of epicardial function in the embryonic or adult diseased
heart. The most overexpressed diffusible factor in BNC1high cells
was nephronectin (NPNT). Nephronectin is the functional ligand of
integrin alpha-8/beta-1, which is overexpressed in the TCF21high
population, suggesting cross-talk between the two populations. A
web application that enables running PCA, t-SNE and clustering, as
well as plotting gene expression, is available at http://www.
bioinformatics.babraham.ac.uk/shiny/epicardium/ (Fig. S3).
Gene ontology analysis predicts different functions for
BNC1high and TCF21high populations
Gene ontology (GO) over-representation analyses suggested a different
phenotypic signature for each population, favouring migration and
muscle differentiation for BNC1high and adhesion/angiogenesis for
TCF21high. Using the genes differentially expressed between the two
populations, we ran GO over-representation analyses using
WebGestalt (Table S3). Fig. 4 and Fig. S4 illustrate results of the
GO term enrichment, after filtering out the terms related to non-cardiac
tissues. Fig. 4 focusses on the terms related to cell and tissue processes
whereas Fig. S4 focusses on the terms related to molecular processes.
The BNC1high population expressed more genes involved in muscle
differentiation, migration and cell-cell interaction. In contrast, the
TCF21high was characterised by adhesion with the term ‘cell-substrate
adhesion’ showing high significance and high specificity to this
population. Moreover, Fig. 4 and Fig. S4 revealed an angiogenic
activity restricted to the TCF21high cells. In particular the GO term
‘blood vessel morphogenesis’ showed high significance, the
highest z-score, with genes highly specific to TCF21high population
(Fig. 4). Furthermore, a large number of genes involved in VEGF
production were expressed specifically in the TCF21high population
(Fig. S4).
THY1 is a membrane marker of the TCF21high population
enriched in CF potential
In order to separate the two populations, we searched for specific
membrane-associated proteins and cell surface receptors. THY1was
Fig. 1. Heterogeneous expression of TCF21 and WT1 in
developing human epicardial cells. (A) Schematic of the
hPSC-epi differentiation protocol. EM, early mesoderm; LPM,
lateral plate mesoderm; RA, retinoic acid. (B) Detection of
WT1 and TCF21 by immunofluorescence in hPSC-epi.
(C) Detection of WT1 and TCF21 by immunofluorescence in
epicardial explant cultures from embryonic human heart at
8 weeks. Blue arrowheads point towards double-negative
cells, pink and green ones towards TCF21 and WT1 single-
positive cells, respectively Scale bars: 20 µm (B); 50 µm (C).
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was expressed at a level 13 times higher in TCF21high than in
BNC1high cells. (Table 1). Immunofluorescence confirmed that the
distribution of the protein THY1 was indeed negatively correlated
with WT1 in our system (Fig. 5A) and to WT1 and BNC1 in
primary human foetal epicardial explants (Fig. 5B,C). As THY1
had not been reported before in the epicardium, we validated its
expression on cryosections of human embryonic hearts at 8 weeks
pc. Immunofluorescence confirmed a heterogeneous expression of
Fig. 2. Characterisation of hPSC-epi heterogeneity by scRNA-seq. (A) Principal component analysis of the gene expression in hPSC-epi cells, showing some
of the main gene influences on PC2. (B) Distribution of expression of TCF21, WT1 and BNC1 in all epicardial cells (232). The numbers of cells for which no
expression is detected are 105, 154 and 44, respectively (represented by the thick line at the bottom of the graph). Boxes represent the inter-quartile range (IQR)
between quartile 1 (Q1=25%) and quartile 3 (Q3=75%); whiskers represent Q1-1.5×IQR and Q3+1.5×IQR. (C) Principal component analysis of the epicardial
cells, coloured by the expression of TCF21, WT1 and BNC1 (see key above), showing the strong alignment with PC2. The lower-right panel presents the overlap
of TC21 (in red) and BNC1 (in turquoise) showing that their expression is exclusive. (D) WT1 and BNC1 detected by immunofluorescence in hPSC-epi. (E) BNC1
distribution in human epicardium at 8 weeks pc. Arrows point towards high-expressing cells, filled arrowheads towards low-expressing cells and empty
arrowheads to negative cells. (F)WT1 and BNC1 detected by immunofluorescence in epicardial explant cultures from embryonic human heart at 8 weeks pc. The
pink arrowheads point toward a single BNC1-positive cell, the blue ones towards double-negative ones. The other cells displayed on the images are double
positive. Scale bars: 30 µm (D); 9 µm (E); 20 µm (F).
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THY1 in the human developing epicardium (Fig. 5D). We used an
anti-THY1 antibody to magnetically separate the two epicardial
populations from constitutive GFP-expressing (GFP+) hPSC-epi
and analyse their capacity to respond to differentiation signals. To
analyse the developmental potential of each population under
normal conditions, we mixed each fraction with non-fractionated
Fig. 3. Transcriptomes of BNC1high and TCF21high subpopulations. (A) tSNE of all hPSC-epi cells, followed by a clustering using partition around medoids
(PAM). (B) Expression of TCF21 (red) and BNC1 (green) showing that themain clusters contain either BNC1 or TCF21 cells whereas the smallest cluster presents
a mix of them. (C) Differential expression analysis between the two main clusters showing the amplitude of changes and their significance. Genes of specific
interest for epicardium function or this study are highlighted. (D) Heat plot of the most differentially expressed genes between the two main clusters showing that
the clustering based on those genes reflects the division based on thewhole transcriptome. Columns are cells, rows are genes. The orange and cyan bar specifies
which cluster shown in A the cell belongs to.
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GFP-negative (GFP−) hPSC-epi cells in equal proportions and
recorded the exact percentage of GFP+ cells at day (D) 0 by flow
cytometry. The two mixes made of [unfractionated GFP− hPSC-epi
and GFP+ THY1+ hPSC-epi] or [GFP− hPSC-epi and GFP+ THY1−
hPSC-epi] were separately cultured in differentiation medium for
SMCs and CFs. The SMC and CF differentiation media, established
previously (Iyer et al., 2015), were made of chemically defined
medium (CDM) supplemented with TGFβ and PDGF−BB or
VEGFB and FGF2, respectively. When subjected to SMC
differentiation, the proportion of GFP+ cells remained unchanged
with both THY1 fractions (Fig. 6Aa, n=5). We stained the cells for
two well-characterised markers of the SMC lineage, calponin
(CNN) and transgelin (TAGLN) (Fig. 6Ab). Amongst the GFP+
cells, we quantified, in four experiments, the percentage of cells
positive for these SMC markers and found a similar percentage for
THY1+ and THY1− origin, indicating they all differentiated well
into SMCs (Fig. 6B).
In the CF differentiation medium, the proportion of GFP+ cells
remained unchanged in the culture containing the THY1+
population but was reduced by more than half (19.5% versus
50%) in the condition containing the THY1− population (Fig. 6Ca,
n=5). We concluded that the THY1− hPSC-epi cells did not survive
well in response to FGF2 and VEGFB. Reviewing the molecular
signature of THY1+ and THY1− populations, which coincided with
the TCF21+ and TCF21− cells, respectively, we noted that NRP1,
one of the receptors for VEGFB, is mostly expressed in the THY1+
fraction (see Table 1), which could give an advantage to THY1+
cells over THY1− in CF conditions.
Furthermore, we immunostained the cultures for synaptotagmin
4 (SYT4) and periostin (POSTN) (Fig. 6Cb). SYT4 has been
identified in our in vitro differentiation system as upregulated in the
hPSC-epi-CF compared with the hPSC-epi or hPSC-epi-SMC
(Fig. S5). POSTN is a well-established marker of CF. To assess
whether the surviving GFP+ hPSC-epi cells coming from the
THY1− origin could acquire a CF signature, we quantified, amongst
the GFP+ cells, the percentage of SYT4- or POSTN-positive cells.
Therewere equivalent numbers of SYT4+ regardless of THY1 status
(Fig. 6D, n=4). However, only 37% of the GFP+ cells expressed
POSTN with a THY1− origin compared with 90% with a THY1+
origin (Fig. 6D, n=4). Thus, those Thy1− cells that do survive CF
conditions respond poorly to the FGF2+VEGFB stimulus to turn
into CF. As only 40% of the THY1− cells survived under CF
differentiation conditions and only 37% of the survivors expressed
POSTN, in total only 15% of the THY1− isolated cells acquired a
CF identity versus 90% for THY1+. Given that we used positive
selection to isolate the TCF21/THY1high population, it is likely that
a number of TCF21/THY1low cells will have been present in the so-
called THY1− fraction; we hypothesise that the CF cells generated
from the THY1− fraction originated in fact from those TCF21/
THY1low cells. Regardless, we can conclude that the THY1+ hPSC-
epi cells had a higher propensity (at least six times higher with the
current data) to become CFs than the THY1− fraction.
A core epicardial transcriptional network is coordinated by
BNC1, TCF21 and WT1
Network inference methods applied to our system positioned BNC1
as a master regulator, sitting on top of an epicardial regulatory
network. To understand better the implications of BNC1, TCF21
and WT1 in the regulation of the epicardial development and
function, we inferred a directed transcriptional regulatory network
using a combination of methods, context likelihood of relatedness
(CLR) and gene network inference with ensemble of trees
(GENIE3), as described in the Materials and Methods. The
variation in the system was generated by using the bulk
sequencing transcriptomic data from different stages of cell
development including SMC differentiated from hPSC-derived
lateral plate mesoderm (pre-epicardial stage in our system), hPSC-
epi, hPSC-epi-CF and hPSC-epi-SMC. We retained the top 100
predicted functional interactions between any transcription factor
and each of BNC1, TCF21 and WT1. BNC1 and TCF21 shared
three interactors, BNC1 and WT1 shared 17 interactors, and WT1
and TCF21 shared 21 interactors. Eleven transcription factors are
interacting with the three baits. The top 100 influences involving
TCF21 showed a balanced picture with 48 influences originating
from TCF21, and 52 targeting TCF21, many influences being
bidirectional. The image was similar for WT1. By contrast, 68% of
influences involving BNC1 originated from this gene (Fig. 7,
Table 2, Table S4), the imbalance being even more striking in the 50
strongest interactions, where only nine influences targeted BNC1.
These findings suggest that BNC1 may be a master regulator of
epicardial function.
BNC1 is necessary for epicardial heterogeneity
To investigate the function of BNC1 in hPSC-epi, we generated
hPSCs that were genetically modified with tetracycline (TET)-
inducible shRNA for BNC1 knockdown. The cells were treated with
TET from the last day of the lateral plate mesoderm stage and during
the entire differentiation to hPSC-epi. qPCR, western blotting and
immunofluorescence showed robust BNC1 silencing under TET
treatment (more than 90% by RT-PCR) (Fig. 8A).
Table 1. Differentially expressed transcription factors, plasma membrane and secreted proteins (only the most significant hits with a mean
expression above a given level are displayed, ranked by increasing adjusted P-value)
Upregulated in BNC1high Upregulated in TCF21high
Transcription factors
(base mean>10)
113 (BNC1, TOX3, MEOX1, ID4, ID2, NFATC2, ARNT2
SMAD6, MYCN, WT1, DPF3, ID1, ELF3, ID3, MAF, TBX18,
ASH2L, SOX6, ZNF415, ZNF624, ZFPM2, ZNF20, CUX1,
NCOR2…)
67 (HOPX, ZNF469, NR0B1, TCF21, TCF19, NR4A1, TBX3,
MYBL2, KLF7, AHR, MBNL3, ETS1, ETV4, HIF1A, ZNF564,





356 (PODXL, LRP2, ITGA6, TMEM98, CDH3, CDH1,
LEPROTL1, SLC34A2, PKHD1L1, AQP1, GPNMB, SLC7A7,
CNTN6, CXADR, SLC4A8, PTPRF, ATP7B, ACKR3,
SLC2A1, SLC16A3, OLR1, TMEM88, S100A10, CD82,
PARM1, PLXNB2, APLP2…)
225 (THY1, S1PR3, PDGFRA, BAMBI, PLD3, ADAM12,
TGFBR3, STRA6, SLC12A8, BEST1, SMIM3, NRP1, ITGA1,




229 (SERPINE3, SEMA3E, NPNT, EDN3, PLTP, OLFML1,
FRZB, SEMA3C, SBSPON, MFGE8, APLP2, GAS6, LAMA5,
LAMB1, COL21A1, FBN2, LAMC1…)
187 (THBS1, TGFBI, FN1, DKK1, FREM1, IGFBP3, COL1A1,
MGP, CXCL14, SERPINE2, VCAN, LUM, COL3A1, MFAP4,
CHI3L1, ADAM12, COL6A2, PRSS23, CCL2…)
All protein types 1454 1040
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We measured the expression of WT1 and TCF21. WT1 was
downregulated 4-fold (Fig. 8B) whereas TCF21 was upregulated
6-fold (Fig. 8C) when hPSC-epi was differentiated under a low level
of BNC1. Double immunostaining against TCF21 and WT1
confirmed that the low-BNC1 hPSC-epi contained a majority of
TCF21high cells (Fig. 8D). As expected, there was also a significant
increase in THY1+ cell proportions (from 35% to 63%) (Fig. 8E).
We also tested the effect of BNC1 knockdown in human foetal
samples by transfecting primary epicardial cultures derived from
foetuses over 10 weeks with small interfering (si) RNA. In line with
the results obtained in the hPSC-epi, the silencing of BNC1 induced
a significant (P=0.02) 5-fold increase in TCF21 expression
(Fig. 8F).
In conclusion, in the absence of BNC1, the hPSC-epi behaves as
a TCF21high population. Therefore, by suppressing the expression of
a single transcription factor, we havemodified the cell heterogeneity
of the hPSC-epi. Thus, we are able to generate a pure TCF21high
epicardial population, without requiring sorting methods, as an
important step to generating fine-tuned subpopulations of epicardial
cells with more specific biological activities.
DISCUSSION
We have defined the extent of molecular and functional
heterogeneity in developing human epicardium by single cell
analysis of an hPSC-epi model and validated our findings in human
foetal epicardium. We first showed that high levels of expression of
TCF21 and WT1 were mutually exclusive. We then identified the
transcription factor BNC1 and the membrane protein THY1 as
markers of the TCF21low and TCF21high populations, respectively.
We discovered that only the TCF21high population can generate
CFs. Using a BNC1 knockdown cell model, we demonstrated that
BNC1 is essential for the presence of the TCF21low population and
required for cellular heterogeneity. Transcriptomics-based network
inference predicted the 100 transcription factors most likely to
interact with WT1, TCF21 and BNC1, providing several other
candidates for the regulation of epicardial function.
Fig. 4. Predicted tissue and cellular specificities of BNC1high and TCF21high cells. Results of gene ontology over-representation and gene expression
differential analyses. Each bubble represents an over-represented GO term, the disk size being proportional to the enrichment. The y-axis presents the
significance of the enrichment and the x-axis indicates if the term enrichment is mostly due to genes over-expressed in BNC1high cells (negative z-scores) or in
TCF21high cells (positive z-scores). Bubble colours show the mean difference of expression, for all the genes annotated by the GO term, between BNC1high cells
(turquoise) and TCF21high cells (red).
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BNC1 is a zinc-finger protein and consequently a putative
transcription factor but its target genes are still unknown. It is mostly
expressed in the basal layers of epidermis, hair follicles and corneal
epithelium where it is important for the proliferation of
keratinocytes (Zhang and Tseng, 2007). It is abundant in the
ovary and testis where it is involved in regulating the proliferation
and survival of germ cells (Zhang et al., 2012). It was found
expressed in the adult epicardium of the mouse and is
downregulated after myocardium injury (Bochmann et al., 2010).
We identified for the first time its expression in epicardium during
human heart development. Our data suggest that it is an upstream
regulator of a transcriptional hierarchy regulating cell identity in the
developing epicardium.
Previous studies on epicardium have suggested cellular
heterogeneity based on its multifunctionality (reviewed by Simões
and Riley, 2018). Yutzey and colleagues demonstrated WT1 and
TCF21 heterogeneity of expression by immunocytochemistry on
mouse and chick developing heart sections (Braitsch et al., 2012).
The Tallquist group have described functional subsets of
epicardium based on PDGFRα or PDGFRβ expression, which
respectively give rise to CFs or coronary SMCs (Smith et al., 2011).
However, the extent of heterogeneity at the single cell level and the
molecular regulation of this heterogeneity remain unclear.
Several recent studies have investigated cellular heterogeneity
within the heart by scRNA-seq. However, none of these studies was
performed with human samples but with mouse and as the entire
heart was analysed, the epicardial fraction was usually too small to
be adequately studied (DeLaughter et al., 2016; Skelly et al., 2018;
Cui et al., 2019). Only two studies, so far, focussed primarily on the
epicardium but both were carried out in zebrafish (Cao et al., 2016;
Weinberger et al., 2018) with Cao et al. focussing only on TCF21+
cells. However, our TCF21high and BNC1high subpopulations seem
to be present inWeinberger’s data, with our BNC1high cells possibly
corresponding to their SEMA3E/PODXL population.
The hPSC-epi system presents the key advantages of in vitro
systems, particularly advantageous to the study of human biology,
such as accessibility for perturbation and analysis, unlimited
number of cells, traceability and quality control. However, it is
essential to validate the hPSC-epi cells in terms of ability to model
events in vivo. Comparison between BNC1high and TCF21high in
differentiation media showed that only TCF21high cells were able to
survive in CF medium whereas both could in SMC conditions.
These data are consistent with studies in the mouse by the Tallquist
group, which identified TCF21 expression as necessary for
differentiation into CFs (Acharya et al., 2012). Our in vitro system
was further validated by their previously mentioned findings, in
which PDGFRα was necessary for CF (Smith et al., 2011) and
PDGFRβ for SMC (Mellgren et al., 2008) development. Similarly,
in the hPSC-epi, only the TCF21high cells expressed PDGFRA
whereas PDGFRB expression was detected in both populations.
Additionally, we have used the system to make predictions about
the molecular regulation of epicardial functions, which require
further validation. We predicted BNC1 to be a potential master
regulator of cell heterogeneity, influencing TCF21 expression and
the percentage of cells in the TCF21high/THY1+ population. We first
validated this discovery in primary foetal epicardial cells by
downregulating BNC1 with siRNA and measuring the effect on
TCF21 expression and the percentage of THY1+ cells. Analogous
studies in vivo using BNC1 gene knockout models in the mouse
would further validate the in vitro findings presented here.
A powerful application of our hPSC-epi subpopulations may be
cell therapy for cardiac repair.Winter and colleagues showed in 2007
that injecting human adult EPDCs generated from an atrial biopsy,
into mouse infarcted myocardium, improved heart recovery (Winter
et al., 2007). We recently showed that hPSC-epi cells increased
cardiac graft size, maturity, vascularisation and cardiac function
when added to hPSC-derived cardiomyocytes as combination
therapy (Bargehr et al., 2019). Primary human EPDCs from foetal
and adult origin display different activation states, which may
explain a more rapid foetal EPDC response to environmental cues
(Moerkamp et al., 2016). Unlike adult cells, foetal cells progressed
through EMT faster, even in the absence of TGFβ signalling, and
foetal epithelial EPDCs already had a mesenchymal signature,
predisposing them to undergo EMT. Our hPSC-epi also possess a
mesenchymal signature (TCF21, THY1, FN1, VIM) and are
predictably closer to foetal than adult epicardium (Patterson et al.,
2012; DeLaughter et al., 2016; Moerkamp et al., 2016), which may
explain why they outperformed adult primary mesenchymal stem cells
in engineered heart tissues (Bargehr et al., 2019).
Although cell therapy using hPSC-epi may be beneficial post-
myocardial infarction, there is the risk of generating excessive CFs,
with subsequent fibrosis leading to ventricular diastolic
dysfunction. Consequently, it may be advantageous to separate
the cells producing CFs from those producing SMCs. Our work
opens the door to this approach by separating the TCF21high from
the BNC1high populations. Because THY1 was identified as a
membrane marker of the TCF21high cells, we sorted them
magnetically using an anti-THY1 antibody. HPSC-epi also
generated a restricted TCF21high population following BNC1
knockdown. However, TCF21high-derived CFs may have fibrotic
potential as well as the possibility of producing deleterious factors
such as DKK1 or fibronectin (Wo et al., 2016; Valiente-Alandi
et al., 2018). Consequently, the BNC1high population may be more
Fig. 5. THY1 expression in epicardium. (A) Immunofluorescence double
labelling for THY1 and WT1 in hPSC-epi. (B,C) Immunofluorescence double
labelling in an epicardial explant from an 8 week pc human embryo for THY1
and WT1 (B) or THY1 and BNC1 (C). (D) THY1 immunofluorescence staining
on a cryosection of a human heart at 8 weeks pc. The regions of high or low
expression of THY1 are indicated by arrows or arrowheads, respectively. Scale
bars: 40 μm (A); 20 μm (B,C); 50 μm (D).
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attractive for cell therapy as these cells do not produce CFs, but do
express promising factors previously noted for their beneficial
properties on cardiomyocytes such as nephronectin (Patra et al.,
2012) and milk fat globule-EGF factor 8 (Deng et al., 2017). It will
be interesting in future studies to knock down TCF21 to see if we
promote the SMC pathway, avoiding a CF fate and potentially
Fig. 6. The THY1+ population retains CF potential. THY1-positive (THY1+) and THY1-negative (THY1−) cells were magnetically separated from GFP-positive
(GFP+) hPSC-epi and mixed with regular GFP-negative hPSC-epi in known proportions measured by flow cytometry. (A) After 12 days of differentiation in SMC
medium, the cultures were analysed by flow cytometry to establish the percentage of GFP-positive cells still present (Aa, n=5) and stained for CNN and TAGLN to
confirm the differentiation (Ab). (B) The percentage of CNN+ or TAGLN+ cells present in the GFP+ fraction were quantified in four experiments (an average of 31
and 40 GFP+ cells from THY1+ and THY1− origin, respectively, were counted in each CNN experiment; an average of 33 and 45 GFP+ cells from THY1+ and
THY1− origin, respectively, were counted in each TAGLN experiment). (C) After 12 days of differentiation in CF medium, the cultures were analysed by flow
cytometry to establish the percentage of GFP-positive cells still present (Ca, n=5; ratio paired t-test performed in Prism 7 from GraphPad) and immunostained for
SYT4 and POSTN (Cb). (D) The percentage of SYT4+ or POSTN+ cells amongst the GFP+ population was quantified (n=4 and ratio paired t-test performed in
Prism 7 fromGraphPad; an average of 215 and 67 GFP+ cells from THY1+ and THY1− origin, respectively, were counted in each SYT4 experiment; an average of
2125 and 442 GFP+ cells from THY1+ and THY1− origin, respectively, were counted in each POSTN experiment). All error bars represent s.e.m. Scale bars:
130 µm (Ab); 80 µm (Cb).
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deleterious secreted factors. However, the situation with hPSC-epi
subpopulations may not be that simple. For example, fibronectin has
been reported to have positive or negative effects depending on the
context (Wang et al., 2013). Moreover, loss of TCF21 leads to
abnormal EPDCs (Braitsch et al., 2012). Furthermore, our
bioinformatics analysis suggested that the angiogenic potential of
the epicardium resides in the TCF21high population. So instead of
using a pure BNC1high hPSC-epi population for cell therapy
following myocardial infarction, it may be preferable to engineer a
BNC1high-enriched population but with attenuated rather than
absent CF potential.
Our work has shown that using the hPSC-epi in association with
next-generation single cell sequencing methods is a powerful
platform to investigate human epicardial heterogeneity and
function. To facilitate further analyses, we have developed a
publicly available web application, which can display the
expression of any gene found expressed in the hPSC-epi overlaid
onto a colour-coded tSNE or PCA plot. This tool enables us to
determine whether a gene is expressed in the hPSC-epi and whether
it is correlated with the expression of other key epicardial genes and
will be of significant value to the field.
The next steps will include refining the biological properties of
the hPSC-epi subpopulations and extending the investigations of
the different pathways identified in this study into in vivo systems.
The potential of each subpopulation for cardiac repair should also be
investigated in animal models of myocardial infarction.
Fig. 7. Core epicardial transcriptional network coordinated byBNC1, TCF21 andWT1. The network is built using the 100 strongest inferred influences between
any of BNC1, TCF21 and WT1 and other transcription factors. The central nodes interact with all three baits, the nodes on the middle circle interact with two of our
baits whereas the nodes on the external circle only interact with one bait. Node colours represent the relative expression of the transcription factor in the two
populations, turquoise for BNC1high and red for TCF21high. The thickness and density of the edges reflect the likelihood of the inferences. Note that because the
network is directed, some pairs of nodes are linked by two edges going in opposite directions, although in most cases only one edge passed our threshold.
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hPSCs (H9 line, Wicell) were maintained as previously described (Iyer
et al., 2015) and tested every 2 months for Mycoplasma contamination.
hPSC differentiation was performed in CDM-PVA [Iscove’s modified
Dulbecco’s medium (Gibco) plus Ham’s F12 NUT-MIX (Gibco) medium
in a 1:1 ratio, supplemented with Glutamax-I, chemically defined lipid
concentrate (Life Technologies), transferrin (15 μg/ml, Roche Diagnostics),
insulin (7 μg/ml, Roche Diagnostics), monothioglycerol (450 μM, Sigma-
Aldrich) and polyvinyl alcohol (PVA, 1 mg/ml, Sigma-Aldrich)] on
gelatin-coated plates. The cells were first differentiated into early
mesoderm with FGF2 (20 ng/ml), LY294002 (10 μM, Sigma-Aldrich)
and BMP4 (10 ng/ml, R&D Systems) for 36 h. Then, they were treated
with FGF2 (20 ng/ml) and BMP4 (50 ng/ml) for 3.5 days to generate
lateral plate mesoderm. The differentiation of lateral plate mesoderm into
epicardium (hPSC-epi) was induced by exposure to Wnt3A (25 ng/ml,
R&D Systems), BMP4 (50 ng/ml) and retinoic acid (4 μM, Sigma-
Aldrich) for 8 to 10 days after dissociation and re-plating of the lateral
plate mesoderm cells at a density of 24,000 cells per cm2.
Magnetic separation of the THY1+ and THY1− hPSC-epi cells was
performed using mouse anti-THY1 antibody clone 5E10 (14-0909-82,
Thermo Fisher Scientific; 1/100), biotinylated horse anti-mouse IgG
antibody (BA-2000, Vector Laboratories; 1/500) and MACS Streptavidin
MicroBeads from Miltenyi Biotec following their instructions.
hPSC-epi-SMC and hPSC-epi-CF were derived from hPSC-epi following
Iyer et al. (2015). Briefly, after splitting, the hPSC-epi cells were cultured for
12 days in CDM-PVA supplemented with PDGF-BB (10 ng/ml, Peprotech)
and TGFβ1 (2 ng/ml, Peprotech) to obtain hPSC-epi-SMC and with VEGFB
(50 ng/ml, Peprotech) and FGF2 (50 ng/ml) to obtain hPSC-epi-CF.
Primary human cultures
Human embryonic and foetal tissues were obtained following therapeutic
pregnancy interruptions performed at Cambridge University Hospitals NHS
Foundation Trust with ethical approval (East of England Research Ethics
Committee) and informed consent in all instances.
For embryonic epicardial explants, 8-week pc embryonic hearts were
harvested and set up under coverslip on gelatin-coated plates (0.1% gelatin
for 20 min at room temperature (RT), followed by advanced DMEM
F12+10% foetal bovine serum for storage at 37°C) and primary epicardium
medium [1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM,
Sigma-Aldrich) and Medium 199 (M199, Sigma-Aldrich) containing
100 U/ml penicillin, 100 μg/ml streptomycin, 10% heat-inactivated foetal
bovine serum (Sigma-Aldrich)]. After a few days, when epicardial cells had
started to explant, SB-435142 (Sigma-Aldrich), 10 µM final concentration,
was added to the medium.
For primary foetal epicardial cultures, the heart was removed from
foetuses over 10 weeks pc. Several patches of the epicardial layer were
peeled off with fine dissecting tweezers and set up to grow in a gelatin-
coated 12-well tissue culture plate in primary epicardial medium. After
5 days in a humidified incubator at 37°C and 5% CO2, the growing cells
were dissociated with TrypLE Express Enzyme (Life Technologies) and
re-plated in primary epicardial medium supplemented with SB-435142
10 μM final concentration. Cells were maintained in the same conditions
and passaged 1:2 when confluent.
For primary human foetal fibroblasts, the foetal hearts were harvested at
8-9 weeks pc, cut into small pieces and digested with collagenase
(collagenase IV, Life Technologies, 17104019) at 0.25% in Dulbecco’s
PBS (DPBS; Thermo Fisher Scientific), for 30 min at 37°C with occasional
re-suspension. Digested tissues were pushed through a 40 µm cell strainer,
washed twice inDPBS and then incubated a further 10 min at 37°C in TrypLE
Express Enzyme to obtain a cell suspension. Cells were seeded at 1.2×107
cells per 75 cm2 on gelatin-coated plates in DMEM (Sigma-Aldrich)
supplementedwith 10% foetal calf serum (Sigma-Aldrich)+1 ng/ml FGF2 for
20 min at 37°C. At that stage, only fibroblasts had time to adhere. The
medium was refreshed in order to remove all the other cell types.
RNA sequencing
Single cell sequencing
Single cells were sorted by flow cytometry into individual wells of a 96-well
plate containing lysis buffer [0.2% (v/v) Triton X-100 and 2 U/μl
SUPERaseIn RNase Inhibitor (Invitrogen)] and stored at −80°C. Single
cell libraries for RNA sequencing were prepared using the Smart-seq2
protocol (Picelli et al., 2014), whereby 21 cycles were used for the cDNA
library pre-amplification. The Illumina Nextera XT DNA sample
Table 2. Top 100 influences between TCF21, WT1 or BNC1 and any
transcription factor
Influencing Influenced by
BNC1 ZFPM2, GATA6, ZNF160,
ZNF35, ZNF777, AR, PURB,
TCF3, ZFHX3, TBX2, SOX4,






























WT1 TCF21, ZNF778, ARNT,










EZH1, HLX, TOX3, GLIS2,
NR0B1, ZSCAN18, ETV1,
HIC1, MAFB, ID4, ZP41,
THAP6, ZNF644, ZBTB1,
DPF3
NR0B1, GATA6, ZNF778, HLX,
TCF21, ZNF616, ZNF83,
NFATC4, NR2C2, ISX,











THAP6, DPF3, IRF1, AHRR,
RXRB, ZNF248, ELF1
TCF21 MEIS1, ZNF778, TSHZ3,
CUX1, NR1D2, GATA3,














GATA3, MEIS1, WT1, HLX,
















Genes are ranked by decreasing likelihood of influences as computed by the
combination of CLR score and GENIE3 rank. The three main regulators
regulate each other (indicated in bold).
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preparation kit and Index Kit (Illumina) were used for cDNA tagmentation
and indexing. Library size and quality were checked using an Agilent High-
Sensitivity DNA chip with Agilent Bioanalyser (Agilent Technologies).
The pooled libraries of 96 cells were sequenced at the Babraham Institute
sequencing facility on an Illumina HiSeq2500 at 100 bp per read. We used
one lane per plate, resulting in 250,000 to 5,800,000 reads per sample.
The quality of the raw data were assessed using FastQC (https://www.
bioinformatics.babraham.ac.uk/projects/fastqc/) for common issues
including low quality of base calling, presence of adaptors among the
sequenced reads or any other over-represented sequences, and abnormal per
base nucleotide percentage. FASTQ files were mapped to theHomo sapiens
genome GRCh38 using HISAT2 (Kim et al., 2015). We removed the 22
Fig. 8. BNC1 function in developing epicardial cells. (A) hPSC-epi developed from TET-inducible knockdown hPSC showed more than 90% reduction in
BNC1 RNA under the TET condition (Aa) and 98% reduction at the protein level by western blot (Ab) as also visualised by immunofluorescence (Ac) (n=5).
(B,C) These cells showed more than 75% reduction ofWT1RNA (B) and a 5-fold increase in TCF21 RNA (C). (D,E) When BNC1 is silenced during its development,
the hPSC-epi is enriched in the TCF21high population as revealed by double immunofluorescence WT1/TCF21 (D) and THY1 flow cytometry analysis [E; histograms
of a representative experiment (top) and recapitulative graph (bottom) of n=5; brackets indicate the percentage of positive cells]. (F) BNC1 silencing can be
achieved in human foetal primaryepicardiumusing siRNAas shownbyRT-PCR (Fa) and immunofluorescence (Fb). The knockdown of BNC1 inhuman foetal primary
epicardium leads to a greater than 5-fold increase inTCF21RNA (Fc) (n=3). The RT-PCRdata shown in Aa, B, C, Fa and Fcwere obtained by the quantitative relative
standard curve protocol as described inMaterials andMethods. RNAmeasurements were normalised to housekeeper genes porphobilinogen deaminase (PBGD) or
GAPDH. Statisticswere performedwith Prism 7 fromGraphPadwith a ratio paired t-test. Error bars represent s.e.m. *P<0.05, **P<0.01, ***P<0.001. Scale bars: 40 μm
(Ac,D); 20 μm (Fb).
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samples (over 384) for which either most of the reads (above 97%) were
mapped to the ERCC spike-in, probably representing empty wells, without
cells, or for which less than 80% of reads were in genes, or for which less
than 2% genes were detected. This represented 2-13 samples per 96-well
plate. Of the remaining 362 cells, 130 were from the lateral plate mesoderm
stage (hPSC-LM) and the 232 others from hPSC-epi. The data have been
deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are
accessible through GEO Series accession number GSE122827.
Preliminary analysis using PCA showed that a few cells were isolated, far
from most of their grouped siblings. Those cells had fewer reads than others
and a low gene count. We therefore removed 36 cells with fewer than
500,000 reads, and expressing fewer than 7000 genes. The expression of
genes was quantified using SeqMonk’s RNA-Seq pipeline (https://www.
bioinformatics.babraham.ac.uk/projects/seqmonk/). Raw read counts
aligned with all exons were summed for each gene.
Bulk sequencing
Total RNAwas extracted from cultures using the RNeasy mini from Qiagen.
DNA contamination was removed from the samples using the DNA-free
DNA Removal Kit from Ambion (Thermo Fisher Scientific). cDNA
synthesis and Illumina libraries were performed using SMARTer Stranded
Total RNA-Seq Kit v2 - Pico Input Mammalian kit from Takara Bio. Unless
otherwise stated, the data from bulk cultures were produced as for the single
cell libraries (see above). We sequenced the 21 libraries on two lanes. The
two BAM files of each samples were then merged, resulting in 10 million to
25 million reads per sample. The data have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series accession
number GSE122714.
The expression of genes was quantified with SeqMonk’s RNA-Seq
pipeline using a further DNA contamination correction because a sample
exhibited homogeneous read coverage in introns and intergenic regions.
Exploration of transcriptomes
For all data analysis except differential expression, the counts were corrected
for library size (counts per million reads). Genes displaying fewer than one
read per million in all samples were discarded, as were genes for which
expression varied by less than 2-fold across all samples. Counts were then
normalised using the rlog function of the DESeq2 R package (Love et al.,
2014). hPCS-epi came from two different experiments, and we found a clear
batch effect, whereas there was no difference between the cells coming from
two different plates sequenced on different lanes. We corrected for the
culture batch effect with the combat function or the sva R package.
PCA was performed using the prcomp function of the stats R package.
t-SNE was carried out using the rtsne R package (van der Maaten, 2014).
Parameters were explored systematically, and better results were obtained
with a perplexity of 30, and a maximum of 2000 iterations. Varying the
acceleration parameter θ between 0 and 0.5 did not change the results
significantly. Clusters were defined by the partitioning around medoids
algorithm using the pam function of the cluster R package.
Differential expression analyses were performed with the DESeq2
package (Love et al., 2014). Significance was set at a P-value adjusted for
multiple testing of 0.01. Over-representation analyses were performed using
WebGestalt (Wang et al., 2017) and the non-redundant version of Gene
Ontology Biological Process branch (Ashburner et al., 2000). The
background for DESeq2-related enrichment was the list of all genes
expressed in at least one cell. We retained all the terms with a P-value
adjusted for multiple testing (FDR) under 0.05. The z-score for each GO
termwas computed as the difference between the number of genes annotated
with this term upregulated in TCF21high and those upregulated in in
BNC1high divided by the square root of their sum.
Network inference
Following the conclusions of the DREAM5 challenge’s analysis (Marbach
et al., 2012), we used a combination of methods based on different
algorithms to infer regulatory networks. We combined the results of CLR
(Faith et al., 2007), a mutual-information-based approach providing
undirected edges, and GENIE3 (Faith et al., 2007; Huynh-Thu et al.,
2010), a tree-based regression approach providing directed edges. Both
methods were the best performers in their category at DREAM5.We applied
the two methods to transcription factor gene expression coming from the
bulk sequencing samples, using filtered CPM as described above. As CLR
only provides undirected edges whereas GENIE3 provides directed ones,
the results of CLR were all mirrored with an identical score on edges in both
directions. Only edges with a positive score in the GENIE3 analysis were
used. The intersect between edges present in CLR and GENIE3 results were
then ranked according to the product of both algorithms’ scores. This only
retains edges that have either an extremely high score with one method, or
consistent scores with both methods. Subnetworks were extracted using
gene lists as seeds, retaining only the first neighbours above a threshold.
Visualisation and analysis of the resulting networks was performed using
Cytoscape (Shannon et al., 2003).
Inducible knockdown (psOPTIkd)
Design and annealing of shRNA oligonucleotides
Oligonucleotides were designed by using the TRC sequence from Sigma-
Aldrich and are shown in Table S5. Hairpin A was selected as a validating
hairpin as it was demonstrated to work previously in downregulating B2M
expression. The oligonucleotides were annealed according to the protocol
supplied by Bertero et al. (2016, 2018) and then ligated into the cut
psOPTIkd vector using T4 ligase for 2 h at RT. The ligation mix was
transformed into alpha select competent cells (BioLine) according to the
manufacturers’ directions. The transformations were plated onto LB agar
plates containing ampicillin before colony PCR screening of transformants.
Colony PCR of transformants
Transformants grown on LB agar plates were picked in the morning after
plating for colony PCR. AAVsingiKD forward (CGAACGCTGACG-
TCATCAACC) and reverse (GGGCTATGAACTAATGACCCCG) primers
were used; thermocycling conditionswere as follows: 95°C for 5 min, then 35
cycles of 95°C for 30 s, 63°C for 30 s and 72°C for 1 min. These PCR
reactions were run on a 1.5% agarose gel, with positive colonies running at
520 bp. Positive colonies were mini prepped (Qiagen mini prep kit, used
according to manufacturers’ directions) before Sanger sequencing through
Source BioScience, using the protocol for strong hairpin structures.
Miniprepped vectors that showed correct insertion of our shRNA sequence
were selected for midiprep (Qiagen) and restriction digest with BamHI to
check vector fragment size.
Vector digestion
Briefly, the psOPTIkd vector (kindly supplied by Ludovic Vallier
laboratory, Wellcome Trust-Medical Research Council Cambridge Stem
Cell Institute) was digested using restriction enzymes BglII and SalI
(Thermo Fisher Scientific) in FastDigest buffer (Thermo Fisher Scientific)
for 30 min at 37°C to allow insertion of different shRNA sequences against
BNC1. The digested vector product was purified with the QIAquick PCR
purification kit (Qiagen) and run on a 0.8% agarose gel before extraction
using the QIAEX II Gel Extraction Kit (Qiagen).
Gene targeting by lipofection
For psOPTiKD of hPSC, AAVS1 targeting was performed by lipofection.
hPSCs were transfected 24-48 h after cell passaging with 4 μg of DNA and
10 μl per well of Lipofectamine 2000 in Opti-MEM media (Gibco),
according to the manufacturer’s instructions. Briefly, cells were washed
twice in PBS before incubation at RT for up to 45 min in 1 ml OptiMEM
(Gibco). While cells were incubated in OptiMEM, DNA-OptiMEM
mixtures were prepared. Mix 1 comprised 4 μg DNA (equally divided
between the two AAVS1 ZFN plasmids, a kind gift from Ludovic Vallier
laboratory, and our shRNA targeting vector) in 250 μl OptiMEM per well of
a six-well plate. Mixture 2 comprised 10 μl Lipofectamine in 250 μl
OptiMEM per well. Mixtures 1 and 2 were prepared and mixed gently
before incubation at RT for 5 min. Then 250 μl of Mixture 2 was added to
250 μl Mixture 1 before incubation at RT for 20 min. Five hundred
microliters of a 1:1 Mixture 1:Mixture 2 transfection mix was added in a
drop-wise spiral manner around the well of hPSCs. Cells were incubated in
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transfection mix at 37°C overnight before washing in CDM-BSA II media
the next day approximately 18 h post-transfection. After 2 days, 1 μg ml−1
of puromycin was added to the CDM-BSA II culture media. Individual
hPSC clones were picked and expanded in culture in CDM-BSA II
following 7-10 days of puromycin selection.
Genotyping siKD hPSC clones
Clones from gene targeting were screened by genomic PCR to verify site-
specific targeting, determine whether allele targeting was heterozygous or
homozygous, and check for off-target integrations of the targeting plasmid.
(See Table S6 for PCR primers and thermocycling conditions and Fig. S6
for PCR results.) All PCRs were performed using 100 ng of genomic DNA
as template in a 25 μl reaction volume using LongAmp Taq DNA
Polymerase (NEB) according to the manufacturer’s instructions, including
2.5% volume dimethyl sulphoxide (DMSO). DNA was extracted using
the genomic DNA extraction kit from Sigma-Aldrich according to the
manufacturer’s instructions.
Inducible BNC1 knockdown
One homozygous-targeted clone for each vector transfection was selected
for subsequent differentiation into hPSC-epi with or without the addition
of 1 μg/ml tetracycline (Sigma-Aldrich) to culture media with the aim
of mediating BNC1 knockdown. hPSC-epi was successfully differentiated
from each clone in the presence and absence of tetracycline. qPCR
analysis indicated that clone 1Ei had a very pronounced reduction in BNC1
(Fig. S7A). Another clonewas generatedwith the vector BNC1-E (1E17) and
this showed the same level of efficiency at downregulating BNC1 (Fig. S7B).
Retroviral transduction
Production of the lentiviral particles
The lentiviral particle supernatant was obtained from transfection of 293T
cells with the lentiviral vector of interest using Mirus TransIT-LT1
transfection reagent and the HIV-1 helper plasmid psPAX2 (Addgene
#12260) and HIV-1 envelope plasmid pMD2.G (Addgene #12259).
Production of fluorescent hPSC lines
While splitting, the H9 cells were transduced with a lentivirus expressing an
EGFP reporter under the control of Ef-1α (EEF1A1) promoter. We used the
lentiviral vector pLVTHM (Addgene #12247).
Immunofluorescence
Primary antibodies were as follows: unconjugated or Alexa Fluor 488-
conjugated rabbit anti-WT1 [CAN-R9(IHC)-56-2] (Abcam, ab89901 or
ab202635; 1/100); rabbit anti-BNC1 (Atlas Antibodies, HPA063183; 1/200);
rabbit anti-TCF21 (Atlas Antibodies, HPA013189; 1/100); mouse anti-THY1
clone 5E10 (Thermo Fisher Scientific, 14-0909-82; 1/100); mouse Anti-
CNN1 (Sigma-Aldrich, C2687; 1/1000); rabbit anti-periostin (Abcam,
ab14041; 1/500); mouse anti-synaptotagmin 4 (Abcam, ab57473; 1/100).
Cultured cells
Cells were fixed using 4% paraformaldehyde (PFA), permeabilised
and blocked with 0.5% Triton X-100/3% BSA/PBS for 60 min at RT.
Unless otherwise stated, primary antibody incubations were performed at 4°C
overnight and Alexa Fluor-tagged secondary antibodies (A21200, A10037,
A21238, A11034, A10042 and A21244, Invitrogen) were applied for 1 h at
RT. Nuclei were counterstained with DAPI (10 μg/ml, Sigma-Aldrich).
For double staining of TCF21/WT1 and BNC1/WT1, TCF21 (or BNC1)
and WT1 were detected sequentially. Anti-TCF21 or anti-BNC1 were first
applied overnight and detected with a Rhodamin-FAB fragment goat anti-
rabbit IgG (H+L) fromAbcam for 1 h at RT. Then, the anti-WT1 conjugated
to Alexa Fluor 488 was incubated for 2 h at RT. For double staining of
THY1/WT1 or THY1/BNC1, the cells were first blocked without
permeabilisation and THY1 was first detected with mouse anti-THY1
followed by incubation with anti-mouse conjugated antibody. The cells
were briefly post-fixed in PFA 4% and then permeabilised with 0.5% Triton
X-100/3% BSA/PBS before being incubated as for anti-WT1 or anti-BNC1.
Images were acquired on a Zeiss LSM 700 confocal microscope and
analysed with ImageJ software. For quantification of the number of GFP+
cells also positive for CF or SMC markers, the number of GFP+ cells was
first measured in the green channel. Then the double-positive or double-
negative (depending on the size of the populations) cells were counted using
the merge images. When few GFP+ cells were present in the image, the cells
were manually counted using the Analyse ImageJ plug-in called ‘cell
counter’ (https://imagej.nih.gov/ij/plugins/cell-counter.html). When too
many GFP+ cells were present to count manually, we used the function
‘Analyse particles’ after adjustment of the threshold and binary
transformation of the image. The double-positive or double-negative cells
were counted using ‘cell counter’.
Cryostat sections
Foetal human hearts were harvested as described for primary human culture
of epicardium. The whole heart was snap-frozen in liquid nitrogen and
stored at −80C before sectioning in a cryostat after embedding in OCT;
10 µm-thick sections were collected onto SuperfrostPlus slides and stored at
−80°C until staining. Staining was performed as described above.
THY1 flow cytometry
Each sample of 106 cells was divided into two tubes. One tube received a
mouse isotype control antibody and the other tube was incubated with
the mouse anti-THY1 antibody, clone 5E10 (both at 5 μg/ml final
concentration) for 1 h at RT. After a rinse in 1× PBS, the cells were re-
suspended in chicken anti-mouse Alexa 488 or donkey anti-mouse Alexa
647 antibody diluted 1/500.
Quantitative real-time polymerase chain reaction
Total RNA was extracted using the RNeasy mini kit (Qiagen). cDNA was
synthesised from 250 ng RNA using the Maxima First Strand cDNA
Synthesis kit (Fermentas). Quantitative real-time polymerase chain reaction
(qRT-PCR) reaction mixtures were prepared with SYBR green PCR master
mix (Applied Biosystems) and run on the 7500 Fast Real-time PCR system
using the quantitative relative standard curve protocol against standards
prepared frompooled cDNA from each experiment.Melt curveswere checked
for each experimental run. CT values were normalised to housekeeper genes
porphobilinogen deaminase (PBGD) or GAPDH. Primers were supplied
by Sigma-Aldrich and sequences were as follows: GAPDH forward:
AACAGCCTCAAGATCATCAGC; GAPDH reverse: GGATGATGTTCT-
GGAGAGCC; WT1 forward: CACAGCACAGGGTACGAGAG; WT1
reverse: CAAGAGTCGGGGCTACTCCA; TCF21 forward: TCCTGGC-
TAACGACAAATACGA; TCF21 reverse: TTTCCCGGCCACCATAAA-
GG; BNC1 forward: GGCCGAGGCTATCAGCTGTACT; BNC1 reverse:
GCCTGGGTCCCATAGAGCAT.
Western blotting
To assess BNC1 levels by immunoblotting, lysate from one confluent well
of hPSC-epi cells in a six-well plate was separated by SDS-PAGE on an 8%
acrylamide gel and transferred overnight onto a PVDF membrane. The
protein was detected using a rabbit anti-BNC1 antibody (HPA063183, Atlas
Antibodies; 1/100) followed by chemiluminescence detection using an
HRP-conjugated secondary antibody, (7074S, NEB; 1/10,000). Mouse anti-
β-tubulin antibody (86298, Cell Signaling Technology; 1/1000) was used as
the housekeeping protein.
BNC1 siRNA-mediated knockdown in human primary foetal
epicardial cells
siRNA-mediated knockdown was performed by transfection via Optimem
(Gibco) and Dharmafect (Dharmacon), and siRNA assays s2011 and
s57438 against BNC1 (Thermo Fisher Scientific) as per the manufacturer’s
directions, with a scrambled siRNA sequence (AllStar) and no siRNA as
controls. Final siRNA concentration was 40 nm.
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